1.Dr.Fan Yang reported the clinical results of the Venetoclax combination therapy for recurrence of acute myeloid leukemia(AML)after allogeneic hematopoietic stem cell transplantation(Allo-HSCT).The title of the report is Clinical observation on Venetoclax-based combinations for adult patients with acute myeloid leukemia relapsing after allogeneic stem cell transplantation

2.Dr.Zhihui Li presented the team's exploration of the effects of genetic variants of blood and immune susceptibility genes on Allo-HSCT outcomes in patients with blood tumors.The report is entitled"Potential influence of hematological or immunological hereditary predisposition genes on outcomes of allogeneic.hematopoietic stem cell transplantation in patients with hematological malignancies

3.Dr.Lin Yuehui's reported"Novel potential treatment modalities for EBF1-PDGFRB fusion gene positive B-cell precursor acute".

4.Dr.Song Yanzhi reported"Busulfan/Fludarabine-based or TBI/Fludarabine-based reduced intensity conditioning regimens in haploidentical stem cell transplantation for acute leukemia".

5.Dr.Zhao Yongqiang reported"Excellent outcomes of second allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning regimens in acute leukemia".

6.Head Nurse Wang Xiaoxia reported"Significance of patient visit by nurse before hematopoietic stem cell transplantation".

7.Head Nurse Tao Xiuyan reported on the successful nursing experience of plasma exchange for post-CAR T cytokine release syndrome.